Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting
Open Access
- 1 July 1994
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 108 (1) , 99-108
- https://doi.org/10.1016/s0022-5223(94)70225-x
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United KingdomThe Annals of Thoracic Surgery, 1993
- High-dose aprotinin therapy: A review of the first five years' experienceJournal of Cardiothoracic and Vascular Anesthesia, 1992
- The effects of aprotinin on hemostatic function during cardiac surgeryJournal of Cardiothoracic and Vascular Anesthesia, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Bleeding complications associated with cardiopulmonary bypassBlood, 1990
- Early and five-year results for coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986
- Repeated assessment of results in clinical trials of cancer treatmentThe British Journal of Radiology, 1971